In-silico Drug Repurposing pipeline for Epilepsy: Integrating Deep Learning and Structure-based Approaches
Lv, X.; Wang, J.; Yuan, Y.; Pan, L.; Guo, J.
Show abstract
Due to considerable global prevalence and high recurrence rate, the pursuit of effective new medication for epilepsy treatment remains an urgent and significant challenge. Drug repurposing emerges as a cost-effective and efficient strategy to combat this disorder. This study leverages the transformer-based deep learning methods coupled with molecular binding affinity calculation to develop a novel in-silico drug repurposing pipeline for epilepsy. The number of candidate inhibitors against 24 target proteins encoded by gain-of-function (GOF) genes implicated in epileptogenesis ranged from zero to several hundreds. Our pipeline has repurposed the medications with most anti-epileptic drugs (AEDs) and nearly half psychiatric medications, highlighting the effectiveness of our pipeline. Furthermore, Lomitapide, a cholesterol-lowering drug, first emerged as particularly noteworthy, exhibiting high binding affinity for 10 targets and verified by molecular dynamics (MD) simulation and mechanism analysis. These findings provided a novel perspective on therapeutic strategies for other central nervous system (CNS) disease.
Matching journals
The top 8 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- AutoMolDesigner for Antibiotic Discovery: An AI-based Open-source Software for Automated Design of Small-molecule Antibiotics 95%
- A Graph Convolutional Network-based screening strategy for rapid identification of SARS-CoV-2 cell-entry inhibitors 95%
- A Simple Way to Incorporate Target Structural Information in Molecular Generative Models 95%
Similar papers in this journal
- Thinking like a structural biologist: A pocket-based 3D molecule generative model fueled by electron density 94%
- From atoms to cells: bridging the gap between potency, efficacy, and safety of small molecules directed at a membrane protein 94%
- HTRF-based identification of small molecules targeting SARS-CoV-2 E protein interaction with ZO-1 PDZ2 94%
Similar papers in this journal
Similar papers in this journal
- A blueprint for high affinity SARS-CoV-2 Mpro inhibitors from activity-based compound library screening guided by analysis of protein dynamics 94%
- Allosteric binders of ACE2 are promising anti-SARS-CoV-2 agents 94%
- A hybrid in silico approach reveals novel inhibitors of multiple SARS-CoV-2 variants 93%
Similar papers in this journal
- A repurposed drug screen identifies compounds that inhibit the binding of the COVID-19 spike protein to ACE2 93%
- Innovative, rapid, high throughput method for drug repurposing in a pandemic - a case study of SARS-CoV-2 and COVID-19 92%
- Machine learning enables accurate and rapid prediction of active molecules against breast cancer cells 91%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.